2018
DOI: 10.1002/epi4.12102
|View full text |Cite
|
Sign up to set email alerts
|

Metabolic etiologies in West syndrome

Abstract: SummaryWest syndrome (WS) is an early life epileptic encephalopathy associated with infantile spasms, interictal electroencephalography (EEG) abnormalities including high amplitude, disorganized background with multifocal epileptic spikes (hypsarrhythmia), and often neurodevelopmental impairments. Approximately 64% of the patients have structural, metabolic, genetic, or infectious etiologies and, in the rest, the etiology is unknown. Here we review the contribution of etiologies due to various metabolic disord… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
25
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 31 publications
(25 citation statements)
references
References 344 publications
(544 reference statements)
0
25
0
Order By: Relevance
“…Beyond TSC, there are rare instances in which a specific metabolic etiology of IS prompts a specific therapeutic intervention, either as an alternative or adjunct to first‐line therapy . The most notable examples include pyridoxine (vitamin B6) dependency (treated with pyridoxine or leucovorin), pyridoxal‐5‐phosphate deficiency (treated with pyridoxal‐5‐phosphate), GLUT1 deficiency (treated with the ketogenic diet), and nonketotic hyperglycinemia (ameliorated to some extent by sodium benzoate and other interventions to promote central glycine clearance).…”
Section: Special Casesmentioning
confidence: 99%
See 1 more Smart Citation
“…Beyond TSC, there are rare instances in which a specific metabolic etiology of IS prompts a specific therapeutic intervention, either as an alternative or adjunct to first‐line therapy . The most notable examples include pyridoxine (vitamin B6) dependency (treated with pyridoxine or leucovorin), pyridoxal‐5‐phosphate deficiency (treated with pyridoxal‐5‐phosphate), GLUT1 deficiency (treated with the ketogenic diet), and nonketotic hyperglycinemia (ameliorated to some extent by sodium benzoate and other interventions to promote central glycine clearance).…”
Section: Special Casesmentioning
confidence: 99%
“…Beyond TSC, there are rare instances in which a specific metabolic etiology of IS prompts a specific therapeutic intervention, either as an alternative or adjunct to first-line therapy. 70 The most notable examples include pyridoxine (vitamin B6) dependency (treated with pyridoxine or leucovorin), pyridoxal-5-phosphate deficiency (treated with pyridoxal-5-phosphate), GLUT1 deficiency (treated with the ketogenic diet), and nonketotic hyperglycinemia (ameliorated to some extent by sodium benzoate and other interventions to promote central glycine clearance). Among these etiology-specific treatments, there is some evidence suggesting that high-dose pyridoxine is effective in the treatment of IS associated with etiologies other than pyridoxine dependency, 71,72 although other evidence suggests little or no benefit.…”
Section: Special Casesmentioning
confidence: 99%
“…causes of IS, although patients with the newly recognized "ISassociated gene" disruptions, such as ARX (Aristaless-related homeobox) and CDKL5 (cyclin-dependent kinase-like 5), and STXBP1 (syntaxin-binding protein 1), may be much more likely to develop IS. 31,35 Third/fourth tier testing could include novel gene testing or repeat brain MRI, since advances in genetic technology occur rapidly, and ongoing myelination may permit visualization of small abnormalities. Despite exhaustive evaluations, a definitive etiology is not found in 30 to 50% of children.…”
Section: Subtle Spasmsmentioning
confidence: 99%
“…There are rare occasions in which a specific metabolic etiology of IS prompts a specific therapeutic intervention, either as an alternative or adjunct to first-line therapy [44]; the most notable examples include pyridoxine (vitamin B6) dependency (treated with pyridoxine or leucovorin), pyridoxal-5-phosphate deficiency (treated with pyridoxal-5-phosphate), glucose transporter type 1 (Glut1) deficiency (treated with the ketogenic diet), and nonketotic hyperglycinemia (ameliorated to some extent by sodium benzoate and other interventions to promote central glycine clearance) [45].…”
Section: Treatment and Prognosismentioning
confidence: 99%